Europe Drug Delivery Devices Market to Grow with a CAGR of 5.25% through 2030

Rising Prevalence of Chronic Diseases and Growing Adoption of Biologics and Biosimilars are factors driving the Europe Drug Delivery Devices market in the forecast period 2026-2030.

According to TechSci Research report, “Europe Drug Delivery Devices Market –Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the Europe Drug Delivery Devices Market stood at USD 120.32 Million in 2024 and is anticipated to grow with a CAGR of 5.25% in the forecast period, 2026-2030. Pharmaceutical companies are increasingly focusing on improving patient compliance and experience, particularly in competitive therapeutic areas. Customized delivery platforms, ergonomic designs, and devices that ensure ease of use are being prioritized during drug development. Collaborations between pharma companies and medtech firms are also increasing, enabling the co-development of integrated therapy-device solutions tailored to patient needs.

Supportive regulatory frameworks from agencies like the European Medicines Agency (EMA) are fostering innovation and facilitating faster market entry of advanced drug delivery technologies. Programs promoting personalized medicine and digital therapeutics further stimulate device development. Additionally, EU initiatives such as the “EU4Health” program aim to strengthen health systems by improving access to advanced medical technologies, including drug delivery solutions.

 Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Europe Drug Delivery Devices Market”

Europe's aging demographic is another crucial driver. The region has one of the highest proportions of elderly populations globally, leading to increased demand for chronic disease management and long-term therapies. Drug delivery devices that support home-based care—such as infusion pumps and prefilled syringes—are increasingly preferred as they reduce the need for hospital visits and enable greater independence for elderly patients. This trend aligns with broader healthcare strategies promoting outpatient care and healthcare system efficiency.

Rapid technological innovation is transforming drug delivery mechanisms across Europe. The integration of digital health technologies—such as connected inhalers, smart pens, and wearable injectors—has led to increased patient adherence and improved therapeutic outcomes. Additionally, the development of biodegradable and targeted delivery systems is gaining momentum, especially in oncology and biologics segments. These innovations not only enhance drug efficacy but also minimize side effects and improve overall patient experience.

The Europe Drug Delivery Devices Market is segmented into Route of Administration, Device, end user, country and company.

Based on its end user, the Hospitals & Clinics category held the largest share of revenue in 2024. Hospitals and clinics consistently serve as the primary healthcare access points for the European population. With rising incidences of chronic diseases such as cancer, diabetes, cardiovascular conditions, and respiratory disorders, these facilities have experienced increased patient volumes that require regular, often complex drug administration. Drug delivery devices—such as infusion pumps, inhalers, auto-injectors, and implantable devices—are critical in managing these conditions. Hospitals and clinics are uniquely positioned to administer these technologies safely and effectively, leading to greater adoption and consequently, higher revenue contribution.

Based on country, the United Kingdom segment is expected to grow during the forecast period, driven by a combination of demographic, technological, regulatory, and healthcare system factors. One of the key contributors is the rising burden of chronic diseases such as diabetes, cancer, and cardiovascular disorders. The aging population further intensifies this need, as older individuals are more likely to suffer from chronic conditions and prefer user-friendly, self-administered solutions. Technological advancements are also playing a pivotal role. The UK is at the forefront of adopting innovative drug delivery systems, including smart and connected devices that improve patient adherence and therapeutic outcomes. Devices such as wearable injectors, controlled-release implants, and non-invasive formats like patches and inhalers are seeing increasing uptake due to their convenience and efficiency. This trend is further supported by a strong research and development ecosystem in the UK, with global pharmaceutical companies and medtech innovators actively investing in device development.

Major companies operating in Europe Drug Delivery Devices Market are:

• F. Hoffmann-La Roche Ltd
• Antares Pharma
• Novartis AG
• 3M Company
• Sulzer Ltd
• Gerresheimer AG
• Sanofi S.A.
• Johnson & Johnson Services, Inc.
• Bayer AG
• GlaxoSmithKline plc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 “The Europe Drug Delivery Devices Market is poised for sustained expansion, underpinned by strong demand-side fundamentals and continuous innovation. As the healthcare landscape shifts toward personalized and home-based care, the role of advanced drug delivery devices will become even more integral in driving therapeutic success and operational efficiency. Stakeholders across the value chain—from device manufacturers to healthcare providers—must remain agile and innovation-driven to capitalize on this evolving opportunity,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Europe Drug Delivery Devices Market - By Product (Open system, Closed system), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Others), By Device (Syringes, Inhalers, Patch Pumps, And Others), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), By Country,  Competition Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of Europe Drug Delivery Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Europe Drug Delivery Devices Market.

Contact

Techsci Research LLC

420 Lexington Avenue,  Suite 300, New York, United States- 10170

Email: [email protected]

M: +13322586602